Your browser doesn't support javascript.
loading
Uncommon Metastasis of Ovarian Dysgerminoma: A Case Report and Review of the Literature.
Tîrnovanu, Mihaela Camelia; Florea, Irina Daniela; Tanase, Adina; Toma, Bogdan Florin; Cojocaru, Elena; Ungureanu, Carmen; Lozneanu, Ludmila.
Afiliação
  • Tîrnovanu MC; Department of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Florea ID; Department of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Tanase A; Department of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Toma BF; Department of Mother and Child Medicine, "Grigore. T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Cojocaru E; Department of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Ungureanu C; Department of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Lozneanu L; Department of Morphofunctional Sciences I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Medicina (Kaunas) ; 57(6)2021 May 27.
Article em En | MEDLINE | ID: mdl-34071828
ABSTRACT
Ovarian malignant germ cell tumors (OMGCT) represent less than 10% of all ovarian tumors. Dysgerminoma is the most common malignant primitive germ cell tumor in young women, known for its curability and low propensity to invade and metastasize when diagnosed early. Herein, we report an unusual type of ovarian dysgerminoma (OD) metastasis with a brief review of the literature, lacking similar reported cases. To our knowledge, although there are several case reports of dysgerminoma metastases with variable anatomic location and presentation, vaginal metastasis has not been previously described. The local or systemic relapse together with local and distant metastasis is considered as an independent predictor of poor survival in patients with OD. In light of the absence of mutations status, our patient successfully responded to therapy. Currently, the patient remains in clinical remission. A specific follow-up plan is ongoing knowing that ovarian dysgerminomas tend to recur most often in the first 2-3 years after treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Embrionárias de Células Germinativas / Disgerminoma Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Medicina (Kaunas) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Embrionárias de Células Germinativas / Disgerminoma Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Medicina (Kaunas) Ano de publicação: 2021 Tipo de documento: Article